People
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The Healthcare Technology Report announced on Nov. 3 its list of the Top 25 Women Leaders in Biotechnology of 2020.
As more and more gene therapies are approved, the elements that determine their success depend, increasingly, on the business decisions made early on.
Abbott is suing their former VP Jerome Clavel over allegations of trade secret theft with intent to share with his new employer, rival diagnostics company Bio-Rad.
On October 30, the company announced the acquisition of long-time collaborator Oscine Corp.
The COVID-19 pandemic changed the biopharma industry and the world irrevocably. The challenges will reverberate even after the pandemic ends, according to panelists at the Cell and Gene Meeting on the Mesa in mid-October.
Both sides claim to be pleased with arbitration results in dispute over Prevail CEO’s alleged breach of contract from time with Allector.
At the University of Southern California, Dr. Eun Ji Chung and Dr. Mitchell Gross are tackling cancer at the nanoscale.
During a Sunday campaign event in Florida, President Donald Trump appeared to hint to the crowd that following the Nov. 3 election, he would terminate the decades-long tenure of Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
BioSpace caught up with Icosavax CEO Adam Simpson to discuss its new vaccine candidate, IVX-411.
PRESS RELEASES